{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T10:14:10Z","timestamp":1783764850661,"version":"3.55.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Research, Development and Innovation Fund of Hungary","award":["Advanced 152363"],"award-info":[{"award-number":["Advanced 152363"]}]},{"name":"National Research, Development and Innovation Fund of Hungary","award":["TKP2021-NKTA-47"],"award-info":[{"award-number":["TKP2021-NKTA-47"]}]},{"name":"National Research, Development and Innovation Fund of Hungary","award":["National Cardiovascular Laboratory Program (RRF-2.3.1\u201321-2022\u201300003)"],"award-info":[{"award-number":["National Cardiovascular Laboratory Program (RRF-2.3.1\u201321-2022\u201300003)"]}]},{"name":"National Research, Development and Innovation Fund of Hungary","award":["Project no. 135784"],"award-info":[{"award-number":["Project no. 135784"]}]},{"name":"National Research, Development and Innovation Fund of Hungary","award":["K20 funding scheme"],"award-info":[{"award-number":["K20 funding scheme"]}]},{"name":"National Research, Development and Innovation Fund of Hungary","award":["the European University for Well-Being (EUniWell) program (grant agreement number: 101004093\/ EUniWell\/EAC-A02-2019 \/ EAC-A02-2019-1)"],"award-info":[{"award-number":["the European University for Well-Being (EUniWell) program (grant agreement number: 101004093\/ EUniWell\/EAC-A02-2019 \/ EAC-A02-2019-1)"]}]},{"name":"National Research, Development and Innovation Fund of Hungary","award":["EK\u00d6P-24-2 University Research Scholarship Program of the Ministry for Culture"],"award-info":[{"award-number":["EK\u00d6P-24-2 University Research Scholarship Program of the Ministry for Culture"]}]},{"name":"National Research, Development and Innovation Fund of Hungary","award":["Innovation"],"award-info":[{"award-number":["Innovation"]}]},{"DOI":"10.13039\/501100011019","name":"National Research, Development and Innovation Office of Hungary","doi-asserted-by":"crossref","award":["2015-1.2.1.-HU-RIZONT-2-25-00016 (INNOBRAIN)"],"award-info":[{"award-number":["2015-1.2.1.-HU-RIZONT-2-25-00016 (INNOBRAIN)"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011019","name":"National Research, Development and Innovation Office of Hungary","doi-asserted-by":"crossref","award":["Mission-driven National Cardiovascular Laboratory Program (2026)"],"award-info":[{"award-number":["Mission-driven National Cardiovascular Laboratory Program (2026)"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100009232","name":"University of Debrecen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009232","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Long COVID affects a substantial proportion of individuals recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, yet its underlying pathophysiology remains poorly understood. Although autoimmunity is increasingly implicated in disease pathogenesis, routine diagnostics frequently fail to detect relevant immune dysregulation. To address this gap, we analyzed sera from Long COVID patients (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u2009114) and pre-pandemic controls (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200936) using tissue-based Western blotting targeting cardiac, pulmonary, and vascular antigens, alongside standard ANA HEp-2 testing. Longitudinal samples were additionally evaluated to assess autoantibody dynamics. Autoantibodies were detected in the majority of patients (83% vs. 53% in controls;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05), showing a dominant cardiovascular pattern. While cardiac (54% vs. 33% in controls;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.16) and pulmonary (34% vs. 30% in controls;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.50) prevalences did not reach significance, vascular autoreactivity was markedly elevated in Long COVID (34% vs. 8% in controls;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05). Responses exhibited broad polyreactivity and IgM dominance, with longitudinal follow-up showing persistent IgM and the emergence of additional isotypes. Clinically, cardiac autoreactivity was associated with hypertension and headache, while the overall autoreactivity correlated with anosmia and ageusia. In contrast, ANA HEp-2 testing showed no discriminatory value or clinical associations. Distinct autoreactivity patterns further aligned with female sex and clinical parameters (C-reactive protein, creatinine, troponin, body mass index). Together, these findings reveal a high burden of tissue-specific autoantibodies invisible to standard ANA screening. This persistent, IgM-skewed profile suggests ongoing immune dysregulation and may reflect a previously underrecognized component of the immunological response in long COVID, highlighting the need for targeted immunodiagnostic approaches beyond routine serology.\n                  <\/jats:p>","DOI":"10.1007\/s11357-026-02286-9","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:27:39Z","timestamp":1778599659000},"page":"3623-3647","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tissue-specific autoantibody signatures reveal immune alterations undetected by routine serology in long COVID"],"prefix":"10.1007","volume":"48","author":[{"given":"Ott\u00f3","family":"Tatai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szil\u00e1rd","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trai Huynh Thanh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Be\u00e1ta Lajszn\u00e9","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Antal-Szalm\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivetta M\u00e1nyin\u00e9","family":"Siket","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tam\u00e1s Bence","family":"Pint\u00e9r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikl\u00f3s","family":"Fagyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Papp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Cs\u00e9csei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lehoczki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gnes","family":"Szappanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Ungvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiham\u00e9r","family":"Moln\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"2286_CR1","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41586-021-03553-9","volume":"594","author":"Z Al-Aly","year":"2021","unstructured":"Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259\u201364. https:\/\/doi.org\/10.1038\/s41586-021-03553-9.","journal-title":"Nature"},{"key":"2286_CR2","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41591-021-01292-y","volume":"27","author":"CH Sudre","year":"2021","unstructured":"Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID. Nat Med. 2021;27:626\u201331. https:\/\/doi.org\/10.1038\/s41591-021-01292-y.","journal-title":"Nat Med"},{"key":"2286_CR3","unstructured":"National Institute for Health and Care Excellence (NICE) the SIGN (SIGN) and the RC of GP (RCGP) (2024) COVID-19 rapid guideline: managing the long-term effects of COVID-19 (NG188)"},{"key":"2286_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaf533","author":"Y Hou","year":"2025","unstructured":"Hou Y, Gu T, Ni Z, et al. Global prevalence of long COVID, its subtypes, and risk factors: an updated systematic review and meta-analysis. Open Forum Infect Dis. 2025. https:\/\/doi.org\/10.1093\/ofid\/ofaf533.","journal-title":"Open Forum Infect Dis"},{"key":"2286_CR5","unstructured":"World Health Organization. (2023) WHO Coronavirus (COVID-19) Dashboard. In: https:\/\/data.who.int\/dashboards\/covid19\/cases . https:\/\/data.who.int\/dashboards\/covid19\/more-resources. Accessed 2 Apr 2026"},{"key":"2286_CR6","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1007\/s11357-024-01165-5","volume":"46","author":"T Molnar","year":"2024","unstructured":"Molnar T, Lehoczki A, Fekete M, et al. Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches. Geroscience. 2024;46:5267\u201386. https:\/\/doi.org\/10.1007\/s11357-024-01165-5.","journal-title":"Geroscience"},{"key":"2286_CR7","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.1016\/j.cell.2024.07.054","volume":"187","author":"MJ Peluso","year":"2024","unstructured":"Peluso MJ, Deeks SG. Mechanisms of long COVID and the path toward therapeutics. Cell. 2024;187:5500\u201329. https:\/\/doi.org\/10.1016\/j.cell.2024.07.054.","journal-title":"Cell"},{"key":"2286_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd3876","author":"Y Zuo","year":"2020","unstructured":"Zuo Y, Estes SK, Ali RA, et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci Transl Med. 2020. https:\/\/doi.org\/10.1126\/scitranslmed.abd3876.","journal-title":"Sci Transl Med"},{"key":"2286_CR9","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1007\/s11357-022-00649-6","volume":"44","author":"M Fagyas","year":"2022","unstructured":"Fagyas M, Nagy B, R\u00e1duly AP, et al. The majority of severe COVID-19 patients develop anti-cardiac autoantibodies. Geroscience. 2022;44:2347\u201360. https:\/\/doi.org\/10.1007\/s11357-022-00649-6.","journal-title":"Geroscience"},{"key":"2286_CR10","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1007\/s11357-023-00887-2","volume":"46","author":"E T\u00f3th","year":"2023","unstructured":"T\u00f3th E, Fagyas M, Nagy B, et al. Distinct subsets of anti-pulmonary autoantibodies correlate with disease severity and survival in severe COVID-19 patients. Geroscience. 2023;46:1561\u201374. https:\/\/doi.org\/10.1007\/s11357-023-00887-2.","journal-title":"Geroscience"},{"key":"2286_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd4585","author":"P Bastard","year":"2020","unstructured":"Bastard P, Rosen LB, Zhang Q, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020. https:\/\/doi.org\/10.1126\/science.abd4585.","journal-title":"Science"},{"key":"2286_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102754","volume":"20","author":"Z Gao","year":"2021","unstructured":"Gao Z, Zhang H, Liu C, Dong K. Autoantibodies in COVID-19: frequency and function. Autoimmun Rev. 2021;20:102754. https:\/\/doi.org\/10.1016\/j.autrev.2021.102754.","journal-title":"Autoimmun Rev"},{"key":"2286_CR13","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1136\/annrheumdis-2020-218009","volume":"79","author":"PG Vlachoyiannopoulos","year":"2020","unstructured":"Vlachoyiannopoulos PG, Magira E, Alexopoulos H, et al. Autoantibodies related to systemic autoimmune rheumatic diseases in severely ill patients with COVID-19. Ann Rheum Dis. 2020;79:1661\u20133. https:\/\/doi.org\/10.1136\/annrheumdis-2020-218009.","journal-title":"Ann Rheum Dis"},{"key":"2286_CR14","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1111\/cts.12805","volume":"13","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Han T, Chen J, et al. Clinical and autoimmune characteristics of severe and critical cases of COVID-19. Clin Transl Sci. 2020;13:1077\u201386. https:\/\/doi.org\/10.1111\/cts.12805.","journal-title":"Clin Transl Sci"},{"key":"2286_CR15","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","volume":"27","author":"A Nalbandian","year":"2021","unstructured":"Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601\u201315. https:\/\/doi.org\/10.1038\/s41591-021-01283-z.","journal-title":"Nat Med"},{"key":"2286_CR16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.12603","volume":"324","author":"A Carf\u00ec","year":"2020","unstructured":"Carf\u00ec A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603. https:\/\/doi.org\/10.1001\/jama.2020.12603.","journal-title":"JAMA"},{"key":"2286_CR17","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S0140-6736(23)00810-3","volume":"401","author":"C Huang","year":"2023","unstructured":"Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2023;401:e21-33. https:\/\/doi.org\/10.1016\/S0140-6736(23)00810-3.","journal-title":"Lancet"},{"key":"2286_CR18","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.4916","author":"S Rajpal","year":"2020","unstructured":"Rajpal S, Tong MS, Borchers J, et al. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection. JAMA Cardiol. 2020. https:\/\/doi.org\/10.1001\/jamacardio.2020.4916.","journal-title":"JAMA Cardiol"},{"key":"2286_CR19","doi-asserted-by":"publisher","first-page":"031","DOI":"10.1055\/s-0039-1683996","volume":"40","author":"L Huppert","year":"2019","unstructured":"Huppert L, Matthay M, Ware L. Pathogenesis of acute respiratory distress syndrome. Semin Respir Crit Care Med. 2019;40:031\u20139. https:\/\/doi.org\/10.1055\/s-0039-1683996.","journal-title":"Semin Respir Crit Care Med"},{"key":"2286_CR20","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1053\/j.gastro.2021.10.040","volume":"162","author":"JW Blackett","year":"2022","unstructured":"Blackett JW, Wainberg M, Elkind MSV, Freedberg DE. Potential long Coronavirus Disease 2019 gastrointestinal symptoms 6 months after coronavirus infection are associated with mental health symptoms. Gastroenterology. 2022;162:648-650.e2. https:\/\/doi.org\/10.1053\/j.gastro.2021.10.040.","journal-title":"Gastroenterology"},{"key":"2286_CR21","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.eprac.2022.02.003","volume":"28","author":"R Pal","year":"2022","unstructured":"Pal R, Joshi A, Bhadada SK, et al. Endocrine follow-up during post-acute COVID-19: practical recommendations based on available clinical evidence. Endocr Pract. 2022;28:425\u201332. https:\/\/doi.org\/10.1016\/j.eprac.2022.02.003.","journal-title":"Endocr Pract"},{"key":"2286_CR22","doi-asserted-by":"publisher","DOI":"10.3892\/mi.2024.208","volume":"5","author":"B Cay\u00f3n Figueroa","year":"2024","unstructured":"Cay\u00f3n Figueroa B, Mendoza Rojas W, Tiburcio Jim\u00e9nez D. Dermatological complications due to post-COVID-19 syndrome: a systematic review. Med Int. 2024;5:9. https:\/\/doi.org\/10.3892\/mi.2024.208.","journal-title":"Med Int"},{"key":"2286_CR23","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1556\/650.2021.32282","volume":"162","author":"Z Szekanecz","year":"2021","unstructured":"Szekanecz Z, V\u00e1lyi-Nagy I. Posztakut COVID\u201319 szindr\u00f3ma. Orv Hetil. 2021;162:1067\u201378. https:\/\/doi.org\/10.1556\/650.2021.32282.","journal-title":"Orv Hetil"},{"key":"2286_CR24","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.ekir.2020.06.013","volume":"5","author":"SY Robbins-Juarez","year":"2020","unstructured":"Robbins-Juarez SY, Qian L, King KL, et al. Outcomes for patients with COVID-19 and acute kidney injury: a systematic review and meta-analysis. Kidney Int Rep. 2020;5:1149\u201360. https:\/\/doi.org\/10.1016\/j.ekir.2020.06.013.","journal-title":"Kidney Int Rep"},{"key":"2286_CR25","doi-asserted-by":"publisher","first-page":"e815","DOI":"10.3399\/BJGP.2021.0265","volume":"71","author":"M Nurek","year":"2021","unstructured":"Nurek M, Rayner C, Freyer A, et al. Recommendations for the recognition, diagnosis, and management of long COVID: a Delphi study. Br J Gen Pract. 2021;71:e815-25. https:\/\/doi.org\/10.3399\/BJGP.2021.0265.","journal-title":"Br J Gen Pract"},{"key":"2286_CR26","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1513\/AnnalsATS.202008-1002OC","volume":"18","author":"KJ Myall","year":"2021","unstructured":"Myall KJ, Mukherjee B, Castanheira AM, et al. Persistent post\u2013COVID-19 interstitial lung disease. An observational study of corticosteroid treatment. Ann Am Thorac Soc. 2021;18:799\u2013806. https:\/\/doi.org\/10.1513\/AnnalsATS.202008-1002OC.","journal-title":"Ann Am Thorac Soc"},{"key":"2286_CR27","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","volume":"75","author":"B Bikdeli","year":"2020","unstructured":"Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol. 2020;75:2950\u201373. https:\/\/doi.org\/10.1016\/j.jacc.2020.04.031.","journal-title":"J Am Coll Cardiol"},{"key":"2286_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/life15030439","volume":"15","author":"OA Caliman-Sturdza","year":"2025","unstructured":"Caliman-Sturdza OA, Gheorghita R, Lobiuc A. Neuropsychiatric manifestations of long COVID-19: a narrative review of clinical aspects and therapeutic approaches. Life. 2025;15:439. https:\/\/doi.org\/10.3390\/life15030439.","journal-title":"Life"},{"key":"2286_CR29","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3390\/medicina61050773","volume":"61","author":"ST H\u0103r\u0219an","year":"2025","unstructured":"H\u0103r\u0219an ST, Sin AI. The involvement and manifestations of SARS-CoV-2 virus in cardiovascular pathology. Medicina (B Aires). 2025;61:773. https:\/\/doi.org\/10.3390\/medicina61050773.","journal-title":"Medicina (B Aires)"},{"key":"2286_CR30","unstructured":"Lazar Jr. I LSrI GelAnalyzer"},{"key":"2286_CR31","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","volume":"185","author":"Y Su","year":"2022","unstructured":"Su Y, Yuan D, Chen DG, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881-895.e20. https:\/\/doi.org\/10.1016\/j.cell.2022.01.014.","journal-title":"Cell"},{"key":"2286_CR32","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.it.2009.04.005","volume":"30","author":"MP Cancro","year":"2009","unstructured":"Cancro MP, Hao Y, Scholz JL, et al. B cells and aging: molecules and mechanisms. Trends Immunol. 2009;30:313\u20138. https:\/\/doi.org\/10.1016\/j.it.2009.04.005.","journal-title":"Trends Immunol"},{"key":"2286_CR33","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.bbi.2020.12.022","volume":"93","author":"C Franke","year":"2021","unstructured":"Franke C, Ferse C, Kreye J, et al. High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms. Brain Behav Immun. 2021;93:415\u20139. https:\/\/doi.org\/10.1016\/j.bbi.2020.12.022.","journal-title":"Brain Behav Immun"},{"key":"2286_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cells10123592","volume":"10","author":"AE Gracia-Ramos","year":"2021","unstructured":"Gracia-Ramos AE, Martin-Nares E, Hern\u00e1ndez-Molina G. New onset of autoimmune diseases following COVID-19 diagnosis. Cells. 2021;10:3592. https:\/\/doi.org\/10.3390\/cells10123592.","journal-title":"Cells"},{"key":"2286_CR35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/cei.13623","volume":"205","author":"AG Richter","year":"2021","unstructured":"Richter AG, Shields AM, Karim A, et al. Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection. Clin Exp Immunol. 2021;205:99\u2013105. https:\/\/doi.org\/10.1111\/cei.13623.","journal-title":"Clin Exp Immunol"},{"key":"2286_CR36","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.jaci.2025.02.005","volume":"155","author":"S Talwar","year":"2025","unstructured":"Talwar S, Harker JA, Openshaw PJM, Thwaites RS. Autoimmunity in long COVID. J Allergy Clin Immunol. 2025;155:1082\u201394. https:\/\/doi.org\/10.1016\/j.jaci.2025.02.005.","journal-title":"J Allergy Clin Immunol"},{"key":"2286_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtauto.2021.100100","volume":"4","author":"G Wallukat","year":"2021","unstructured":"Wallukat G, Hohberger B, Wenzel K, et al. Functional autoantibodies against G-protein coupled receptors in patients with persistent long-COVID-19 symptoms. J Transl Autoimmun. 2021;4:100100. https:\/\/doi.org\/10.1016\/j.jtauto.2021.100100.","journal-title":"J Transl Autoimmun"},{"key":"2286_CR38","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0022-1759(98)00074-X","volume":"216","author":"S Lacroix-Desmazes","year":"1998","unstructured":"Lacroix-Desmazes S, Kaveri SV, Mouthon L, et al. Self-reactive antibodies (natural autoantibodies) in healthy individuals. J Immunol Methods. 1998;216:117\u201337. https:\/\/doi.org\/10.1016\/S0022-1759(98)00074-X.","journal-title":"J Immunol Methods"},{"key":"2286_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.617089","author":"A Vojdani","year":"2021","unstructured":"Vojdani A, Vojdani E, Kharrazian D. Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: implications for autoimmune diseases. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2020.617089.","journal-title":"Front Immunol"},{"key":"2286_CR40","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1615\/CritRevImmunol.2020034603","volume":"40","author":"KD Moudgil","year":"2020","unstructured":"Moudgil KD. Viewing autoimmune pathogenesis from the perspective of antigen processing and determinant hierarchy. Crit Rev Immunol. 2020;40:329\u201339. https:\/\/doi.org\/10.1615\/CritRevImmunol.2020034603.","journal-title":"Crit Rev Immunol"},{"key":"2286_CR41","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1046\/j.1523-1747.1998.00107.x","volume":"110","author":"LS Chan","year":"1998","unstructured":"Chan LS, Vanderlugt CJ, Hashimoto T, et al. Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol. 1998;110:103\u20139. https:\/\/doi.org\/10.1046\/j.1523-1747.1998.00107.x.","journal-title":"J Invest Dermatol"},{"key":"2286_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/v11080762","author":"MK Smatti","year":"2019","unstructured":"Smatti MK, Cyprian FS, Nasrallah GK, et al. Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms. Viruses. 2019. https:\/\/doi.org\/10.3390\/v11080762.","journal-title":"Viruses"},{"key":"2286_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1509289","author":"Y Galipeau","year":"2025","unstructured":"Galipeau Y, Cooper C, Langlois M-A. Autoantibodies in COVID-19: implications for disease severity and clinical outcomes. Front Immunol. 2025. https:\/\/doi.org\/10.3389\/fimmu.2024.1509289.","journal-title":"Front Immunol"},{"key":"2286_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04515-7","volume":"21","author":"M Ruiz-Pablos","year":"2023","unstructured":"Ruiz-Pablos M, Paiva B, Zabaleta A. Epstein-Barr virus-acquired immunodeficiency in myalgic encephalomyelitis-is it present in long COVID? J Transl Med. 2023;21:633. https:\/\/doi.org\/10.1186\/s12967-023-04515-7.","journal-title":"J Transl Med"},{"key":"2286_CR45","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/s1388-9842(02)00010-7","volume":"4","author":"ALP Caforio","year":"2002","unstructured":"Caforio ALP, Mahon NJ, Tona F, McKenna WJ. Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur J Heart Fail. 2002;4:411\u20137. https:\/\/doi.org\/10.1016\/s1388-9842(02)00010-7.","journal-title":"Eur J Heart Fail"},{"key":"2286_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40047-w","volume":"14","author":"MG Noval","year":"2023","unstructured":"Noval MG, Spector SN, Bartnicki E, et al. MAVS signaling is required for preventing persistent chikungunya heart infection and chronic vascular tissue inflammation. Nat Commun. 2023;14:4668. https:\/\/doi.org\/10.1038\/s41467-023-40047-w.","journal-title":"Nat Commun"},{"key":"2286_CR47","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1007\/s15010-023-02164-y","volume":"52","author":"J Sbierski-Kind","year":"2024","unstructured":"Sbierski-Kind J, Schlickeiser S, Feldmann S, et al. Persistent immune abnormalities discriminate post-COVID syndrome from convalescence. Infection. 2024;52:1087\u201397. https:\/\/doi.org\/10.1007\/s15010-023-02164-y.","journal-title":"Infection"},{"key":"2286_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/life13112121","volume":"13","author":"A Mohan","year":"2023","unstructured":"Mohan A, Iyer VA, Kumar D, et al. Navigating the post-COVID-19 immunological era: understanding long COVID-19 and immune response. Life. 2023;13:2121. https:\/\/doi.org\/10.3390\/life13112121.","journal-title":"Life"},{"key":"2286_CR49","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/imr.12741","volume":"288","author":"SA Jenks","year":"2019","unstructured":"Jenks SA, Cashman KS, Woodruff MC, et al. Extrafollicular responses in humans and SLE. Immunol Rev. 2019;288:136\u201348. https:\/\/doi.org\/10.1111\/imr.12741.","journal-title":"Immunol Rev"},{"key":"2286_CR50","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.2174\/1568026621666210727170147","volume":"21","author":"M Maes","year":"2021","unstructured":"Maes M, Kubera M, Stoyanova K, Leunis J-C. The reification of the clinical diagnosis of myalgic encephalomyelitis\/ chronic fatigue syndrome (ME\/CFS) as an immune and oxidative stress disorder: construction of a data-driven nomothethic network and exposure of ME\/CFS subgroups. Curr Top Med Chem. 2021;21:1488\u201399. https:\/\/doi.org\/10.2174\/1568026621666210727170147.","journal-title":"Curr Top Med Chem"},{"key":"2286_CR51","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1172\/JCI138062","volume":"130","author":"AC Steere","year":"2020","unstructured":"Steere AC. Posttreatment Lyme disease syndromes: distinct pathogenesis caused by maladaptive host responses. J Clin Invest. 2020;130:2148\u201351. https:\/\/doi.org\/10.1172\/JCI138062.","journal-title":"J Clin Invest"},{"key":"2286_CR52","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/imr.12380","volume":"269","author":"MS Naradikian","year":"2016","unstructured":"Naradikian MS, Hao Y, Cancro MP. Age-associated B cells: key mediators of both protective and autoreactive humoral responses. Immunol Rev. 2016;269:118\u201329. https:\/\/doi.org\/10.1111\/imr.12380.","journal-title":"Immunol Rev"},{"key":"2286_CR53","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1007\/s10875-010-9501-7","volume":"31","author":"D Frasca","year":"2011","unstructured":"Frasca D, Blomberg BB. Aging affects human B cell responses. J Clin Immunol. 2011;31:430\u20135. https:\/\/doi.org\/10.1007\/s10875-010-9501-7.","journal-title":"J Clin Immunol"},{"key":"2286_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00318","author":"S Ma","year":"2019","unstructured":"Ma S, Wang C, Mao X, Hao Y. B cell dysfunction associated with aging and autoimmune diseases. Front Immunol. 2019. https:\/\/doi.org\/10.3389\/fimmu.2019.00318.","journal-title":"Front Immunol"},{"key":"2286_CR55","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1136\/ard.2009.127100","volume":"69","author":"PL Meroni","year":"2010","unstructured":"Meroni PL, Schur PH. ANA screening: an old test with new recommendations. Ann Rheum Dis. 2010;69:1420\u20132. https:\/\/doi.org\/10.1136\/ard.2009.127100.","journal-title":"Ann Rheum Dis"},{"key":"2286_CR56","doi-asserted-by":"publisher","first-page":"243","DOI":"10.5114\/reum.2018.77976","volume":"56","author":"B Grygiel-G\u00f3rniak","year":"2018","unstructured":"Grygiel-G\u00f3rniak B, Rogacka N, Puszczewicz M. Antinuclear antibodies in healthy people and non-rheumatic diseases - diagnostic and clinical implications. Reumatologia. 2018;56:243\u20138. https:\/\/doi.org\/10.5114\/reum.2018.77976.","journal-title":"Reumatologia"},{"key":"2286_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2025.1609768","author":"A Teymourzadeh","year":"2025","unstructured":"Teymourzadeh A, Abramov D, Norouzi S, et al. Infection to hypertension: A review of post-COVID-19 new-onset hypertension prevalence and potential underlying mechanisms. Front Cardiovasc Med. 2025. https:\/\/doi.org\/10.3389\/fcvm.2025.1609768.","journal-title":"Front Cardiovasc Med"},{"key":"2286_CR58","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s11357-024-01487-4","volume":"47","author":"M Fekete","year":"2025","unstructured":"Fekete M, Lehoczki A, Szappanos \u00c1, et al. Cerebromicrovascular mechanisms contributing to long COVID: implications for neurocognitive health. Geroscience. 2025;47:745\u201379. https:\/\/doi.org\/10.1007\/s11357-024-01487-4.","journal-title":"Geroscience"},{"key":"2286_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms27010433","author":"M Stojanovic","year":"2025","unstructured":"Stojanovic M, Djuric M, Nenadic I, et al. Vascular complications of long COVID-from endothelial dysfunction to systemic thrombosis: A systematic review. Int J Mol Sci. 2025. https:\/\/doi.org\/10.3390\/ijms27010433.","journal-title":"Int J Mol Sci"},{"key":"2286_CR60","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae080","volume":"6","author":"CD Owens","year":"2024","unstructured":"Owens CD, Bonin Pinto C, Detwiler S, et al. Neurovascular coupling impairment as a mechanism for cognitive deficits in COVID-19. Brain Commun. 2024;6:fcae080. https:\/\/doi.org\/10.1093\/braincomms\/fcae080.","journal-title":"Brain Commun"},{"key":"2286_CR61","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41586-023-06651-y","volume":"623","author":"J Klein","year":"2023","unstructured":"Klein J, Wood J, Jaycox JR, et al. Distinguishing features of long COVID identified through immune profiling. Nature. 2023;623:139\u201348. https:\/\/doi.org\/10.1038\/s41586-023-06651-y.","journal-title":"Nature"},{"key":"2286_CR62","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.169515","author":"A Bodansky","year":"2023","unstructured":"Bodansky A, Wang C-Y, Saxena A, et al. Autoantigen profiling reveals a shared post-COVID signature in fully recovered and long COVID patients. JCI Insight. 2023. https:\/\/doi.org\/10.1172\/jci.insight.169515.","journal-title":"JCI Insight"},{"key":"2286_CR63","doi-asserted-by":"publisher","unstructured":"Son K, Jamil R, Chowdhury A, et al (2022) Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long-COVID symptoms. European Respiratory Journal 2200970. https:\/\/doi.org\/10.1183\/13993003.00970-2022","DOI":"10.1183\/13993003.00970-2022"},{"key":"2286_CR64","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/cid\/ciab611","volume":"74","author":"J See\u00dfle","year":"2022","unstructured":"See\u00dfle J, Waterboer T, Hippchen T, et al. Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clin Infect Dis. 2022;74:1191\u20138. https:\/\/doi.org\/10.1093\/cid\/ciab611.","journal-title":"Clin Infect Dis"},{"key":"2286_CR65","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1093\/cid\/ciab890","volume":"74","author":"MJ Peluso","year":"2022","unstructured":"Peluso MJ, Thomas IJ, Munter SE, et al. Lack of antinuclear antibodies in convalescent coronavirus disease 2019 patients with persistent symptoms. Clin Infect Dis. 2022;74:2083\u20134. https:\/\/doi.org\/10.1093\/cid\/ciab890.","journal-title":"Clin Infect Dis"},{"key":"2286_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.981532","author":"F Sotzny","year":"2022","unstructured":"Sotzny F, Filgueiras IS, Kedor C, et al. Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in post COVID syndrome correlate with symptom severity. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.981532.","journal-title":"Front Immunol"},{"key":"2286_CR67","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.015989","author":"I Kharraziha","year":"2020","unstructured":"Kharraziha I, Axelsson J, Ricci F, et al. Serum activity against G protein\u2013coupled receptors and severity of orthostatic symptoms in postural orthostatic tachycardia syndrome. J Am Heart Assoc. 2020. https:\/\/doi.org\/10.1161\/JAHA.120.015989.","journal-title":"J Am Heart Assoc"},{"key":"2286_CR68","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.113.000755","author":"H Li","year":"2014","unstructured":"Li H, Yu X, Liles C, et al. Autoimmune basis for postural tachycardia syndrome. J Am Heart Assoc. 2014. https:\/\/doi.org\/10.1161\/JAHA.113.000755.","journal-title":"J Am Heart Assoc"},{"key":"2286_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.1012668","author":"NW Larsen","year":"2022","unstructured":"Larsen NW, Stiles LE, Shaik R, et al. Characterization of autonomic symptom burden in long COVID: A global survey of 2,314 adults. Front Neurol. 2022. https:\/\/doi.org\/10.3389\/fneur.2022.1012668.","journal-title":"Front Neurol"},{"key":"2286_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00435-w","volume":"6","author":"D Yang","year":"2021","unstructured":"Yang D, Zhou Q, Labroska V, et al. G protein-coupled receptors: structure- and function-based drug discovery. Signal Transduct Target Ther. 2021;6:7. https:\/\/doi.org\/10.1038\/s41392-020-00435-w.","journal-title":"Signal Transduct Target Ther"},{"key":"2286_CR71","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jacbts.2024.09.007","volume":"10","author":"M Brambilla","year":"2025","unstructured":"Brambilla M, Fumoso F, Conti M, et al. Low-grade inflammation in long COVID syndrome sustains a persistent platelet activation associated with lung impairment. JACC Basic Transl Sci. 2025;10:20\u201339. https:\/\/doi.org\/10.1016\/j.jacbts.2024.09.007.","journal-title":"JACC Basic Transl Sci"},{"key":"2286_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s42358-022-00264-1","volume":"62","author":"WFS Santos","year":"2022","unstructured":"Santos WFS, Cantu\u00e1ria A, F\u00e9lix D, et al. The influence of demography and referral medical specialty on the detection of autoantibodies to HEP-2 cells in a large sample of patients. Adv Rheumatol. 2022;62:32. https:\/\/doi.org\/10.1186\/s42358-022-00264-1.","journal-title":"Adv Rheumatol"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02286-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-026-02286-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02286-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T10:10:15Z","timestamp":1783764615000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-026-02286-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":72,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["2286"],"URL":"https:\/\/doi.org\/10.1007\/s11357-026-02286-9","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer."}},{"value":"Dr. Zoltan Ungvari serves as Editor-in-Chief for GeroScience.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}